
Loading, please wait...

Loading, please wait...

Managing pediatric moyamoya and MAS (Middle Aortic Syndrome) involves balancing two contradictory vascular conditions. While MAS often causes severe systemic hypertension, Moyamoya arteriopathy requires adequate blood pressure to maintain cerebral perfusion. Treating the aortic disease can inadvertently drop blood pressure. Consequently, this drop may trigger a stroke in a vulnerable child. Clinicians must navigate these demands with extreme caution and multidisciplinary planning.
A recent retrospective review from Boston Children’s Hospital analyzed eleven patients with these comorbid conditions. Most patients initially presented with symptoms of brain ischemia. Interestingly, the study found that treating the aortic disease first poses a significant risk. Although aortic repair corrects hypertension, the resulting relative hypotension can lead to cerebral hypoperfusion. Therefore, the multidisciplinary team typically recommends performing moyamoya revascularization before addressing the aortic narrowing.
The study results revealed that blood pressure requirements fluctuated significantly after surgery. Following moyamoya revascularization, some patients required more intensive antihypertensive therapy. Conversely, some patients needed less medication. Furthermore, major perioperative complications, including strokes, occurred during both renal and aortic interventions. This highlights the high-risk nature of these cases. By stabilizing cerebral blood flow first, surgeons create a safety margin for subsequent blood pressure changes during aortic reconstruction.
Successful management requires a coordinated effort between neurosurgeons, cardiologists, and anesthesiologists. Early neurological intervention appears to be a viable strategy to reduce the overall risk of stroke. In addition, patients require long-term follow-up to monitor both cerebral and systemic vascular health. Specialists should evaluate each child individually to determine the optimal timing for these complex procedures.
The primary risk is a sudden drop in blood pressure after aortic repair. This relative hypotension can cause a stroke in patients with Moyamoya because their brains rely on higher pressure to force blood through narrowed arteries.
Moyamoya revascularization surgery improves collateral blood flow to the brain. This makes the brain more resilient to the blood pressure fluctuations and potential hypotension that occur during or after MAS surgery.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.
References
Lopes C et al. Management of pediatric patients with moyamoya arteriopathy and middle aortic syndrome: a retrospective single-institution case series. J Neurosurg Pediatr. 2026 Mar 13. doi: 10.3171/2025.11.PEDS25460. PMID: 41825070.
Rumman RK, et al. (2015). Middle aortic syndrome and moyamoya: A case series and review of the literature. Pediatric Nephrology.
Brzezinski M, et al. (2021). Anesthetic Management of Pediatric Patients With Moyamoya Disease and Co-existing Vascular Anomalies. Journal of Neurosurgical Anesthesiology.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Managing comorbid Moyamoya and MAS in children is complex. A study suggests prioritizing brain revascularization before aortic repair to reduce stroke risk....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today